These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35352855)

  • 41. Healthcare resource utilization and costs in 23-25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany - a retrospective analysis of statutory health insurance claims data.
    Reuschenbach M; Mihm S; Wölle R; Schneider KM; Jacob C; Greiner W; Hampl M; Goodman E
    BMC Health Serv Res; 2022 Aug; 22(1):1002. PubMed ID: 35932066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States.
    Williams PV; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):69-83. PubMed ID: 29429043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims.
    Sacks NC; Healey BE; Cyr PL; Slocomb T; James E; Beggs AH; Graham RJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1019-1026. PubMed ID: 33843254
    [No Abstract]   [Full Text] [Related]  

  • 44. Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
    Tepper SJ; Fang J; Zhou L; Shen Y; Vo P; Abdrabboh A; Glassberg MB; Ferraris M
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1157-1170. PubMed ID: 33998825
    [No Abstract]   [Full Text] [Related]  

  • 45. Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims Study.
    Elsaid MI; John T; Li Y; Koduru S; Ali SZ; Catalano C; Narayanan N; Rustgi VK
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1377-1386. PubMed ID: 31778618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
    Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P
    J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis.
    Huang Q; Borra S; Li J; Wang L; Shrestha S; Sundaram M; Janjan N
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1266-1275. PubMed ID: 32880204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel.
    Melzer Cohen C; Hallén N; Chodick G; Bourvine L; Waner T; Karasik A
    Value Health Reg Issues; 2020 Sep; 22():83-92. PubMed ID: 32798839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies.
    Harberson J; Thomas RM; Harbison SP; Parkman HP
    Dig Dis Sci; 2010 Feb; 55(2):359-70. PubMed ID: 19997975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased Health Care Resource Utilization and Costs Associated with Herpes Zoster Among Patients Aged ≥50 Years with Chronic Obstructive Pulmonary Disease in the United States.
    Ghaswalla P; Thompson-Leduc P; Cheng WY; Kunzweiler C; Wang MJ; Bogart M; Patterson BJ; Duh MS; Wojciehowski J; Park S; Yawn BP
    Chronic Obstr Pulm Dis; 2021 Oct; 8(4):502-516. PubMed ID: 34614552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic burden of spinal muscular atrophy in the United States: a contemporary assessment.
    Droege M; Sproule D; Arjunji R; Gauthier-Loiselle M; Cloutier M; Dabbous O
    J Med Econ; 2020 Jan; 23(1):70-79. PubMed ID: 31322019
    [No Abstract]   [Full Text] [Related]  

  • 52. The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Womens Health (Lond); 2020; 16():1745506520965898. PubMed ID: 33357086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids.
    Shih V; Banks E; Bonine NG; Harrington A; Stafkey-Mailey D; Yue B; Ye JM; Fuldeore RM; Gillard P
    Curr Med Res Opin; 2019 Nov; 35(11):1925-1935. PubMed ID: 31290716
    [No Abstract]   [Full Text] [Related]  

  • 54. Economic Burden of Metastatic Ovarian Cancer in a Commercially Insured Population: A Retrospective Cohort Analysis.
    Chin L; Hansen RN; Carlson JJ
    J Manag Care Spec Pharm; 2020 Aug; 26(8):962-970. PubMed ID: 32715961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus.
    Duan X; Li Y; Liu Q; Liu L; Li C
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):513-521. PubMed ID: 31456456
    [No Abstract]   [Full Text] [Related]  

  • 56. Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States.
    Bell CF; Blauer-Peterson C; Mao J
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1249-1259. PubMed ID: 34165321
    [No Abstract]   [Full Text] [Related]  

  • 57. Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis.
    Bernard CE; Gibbons SJ; Mann IS; Froschauer L; Parkman HP; Harbison S; Abell TL; Snape WJ; Hasler WL; McCallum RW; Sarosiek I; Nguyen LA; Koch KL; Tonascia J; Hamilton FA; Kendrick ML; Shen KR; Pasricha PJ; Farrugia G;
    Neurogastroenterol Motil; 2014 Sep; 26(9):1275-84. PubMed ID: 25041465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US.
    Milentijevic D; Germain G; Laliberté F; Bookhart BK; MacKnight SD; Tsang J; Lefebvre P
    J Med Econ; 2020 Nov; 23(11):1365-1374. PubMed ID: 32897766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States.
    Ryan CJ; Ke X; Lafeuille MH; Romdhani H; Kinkead F; Lefebvre P; Petrilla A; Pulungan Z; Kim S; D'Andrea DM; Francis P; Freedland SJ
    J Urol; 2021 Dec; 206(6):1420-1429. PubMed ID: 34293915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
    Feldman SR; Zhao Y; Shi L; Tran MH
    J Manag Care Spec Pharm; 2015 Oct; 21(10):874-88. PubMed ID: 26402388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.